WIRB-Copernicus Group’s Chief Compliance Officer to Discuss Potential Impact of Corporate Consolidation on Human Research Protection Program Accreditation at 2014 AAHRPP Annual Conference
PRINCETON, N.J., April 23, 2014 /PRNewswire/ — The WIRB-Copernicus Group (“WCG”), the world’s largest provider of regulatory and ethical review services for clinical research, announced today that David Forster, J.D., M.A., C.I.P., the Company’s Chief Compliance Officer, will be a featured speaker at the 2014 Association for the Accreditation of Human Research Protection Programs, Inc. (AAHRPP) Annual Conference being held April 23-25 in Salt Lake City, Utah.
On Thursday, April 24, Mr. Forster will present “Alternative Methods to Documenting Consent” (2:45pm MDT). On Friday, April 25, Mr. Forster will join industry professionals Elyse Summers, J.D., Chief Executive Officer for AAHRPP, and Ivy Tillman, M.S., C.C.R.C., C.I.P., Director of Human Protections at Georgia Regents University, in a discussion of mergers and acquisitions in the clinical research space in a session entitled: “Mergers, Acquisitions, Consolidations: What They Mean for Your Accreditation” (10:45am MDT).
“Our goal is to ensure that clinical scientists are conducting the highest quality scientific research and that human participants are protected through every step of the process,” says Forster. “We appreciate this opportunity to share some lessons learned from the more than 3,000 studies we review every year.”
Serving as Chief Compliance Officer for the WIRB-Copernicus Group, Mr. Forster is responsible for assuring that all proposed research complies with FDA and HHS regulations, ICH guidance and AAHRPP accreditation requirements, as well as any applicable state and agency-specific regulations. He brings extensive knowledge of ethics, quality and human research protection standards to his presentations at the AAHRPP Annual Conference.
For more information about the 2014 AAHRPP Annual Conference, please visit: http://www.aahrpp.org/grow/aahrpp-learning-opportunities/annual-conference.
About The WIRB-Copernicus Group
The WIRB-Copernicus Group (WCG) is the world’s largest and most trusted provider of regulatory and ethical review services for human research. The pioneer of independent ethical review, WCG continues to drive ingenuity in the clinical research space. Today, WCG’s solutions are built upon the foundation of ethical review, but have grown to include a suite of complementary services and technologies that expand the capabilities of the modern research professional. WCG delivers transformational solutions that stimulate growth, foster compliance, and maximize efficiency for those who perform clinical trials.
WCG is proud to serve the individuals on the frontlines of science and medicine, and the organizations that strive to develop new products and therapies to improve the quality of human health. It is our role to empower them to accelerate advancement, while ensuring that the risks of progress never outweigh the value of human life.
For more information, please visit www.wcgclinical.com.
SOURCE WIRB-Copernicus Group